Company Long-Term Loans and Borrowings: enlivex.com (ENLV)
The primary risks for Enlivex Therapeutics (ENLV) are linked to the capital intensity of cell technologies and the complexity of combating sepsis. The business relies on developing macrophage reprogramming methods, which promises high margins upon mass production. Stability is ensured by a strong Israeli staff of scientists and the hiring of specialized managers. Debt stands at 0.00, which is reflected in the chart of the asset's value on the GURU.Markets platform.
Enlivex Therapeutics Ltd. (ENLV) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Enlivex Therapeutics|ENLV - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Enlivex Therapeutics Ltd|ENLV - Company Debts|Debt to Book Value Enlivex Therapeutics|ENLV - Company Long-Term Debt|Company Current Liabilities Enlivex Therapeutics|Quick Ratio enlivex.com
- earnings and multiples data:
Analysis of all company metrics:ENLV - Enlivex Therapeutics
This indicator captures the total volume of liabilities with maturities exceeding twelve months, allowing for an assessment of the issuer's long-term debt load and financial stability. By analyzing the dynamics of the firm's long-term borrowings, an investor can identify the resource base for scaling the R&D pipeline, which is critically important for Enlivex Therapeutics (ENLV) during the accelerated development of Allocetra drugs for sepsis and tumors.
Competitors of Enlivex Therapeutics (ENLV)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|Long-Term Debt Immunome Bio|Gossamer Bio, Inc. (GOSS) - Company Long-Term Debt|Company Long-Term Indebtedness KALV|Company Long-Term Debt Septerna|Company Long-Term Debt PVLA|Company Long-Term Debts SVRA|Long-Term Debt Volume Rigel Corp|AnaptysBio, Inc. - Company Long-Term Liabilities|astriatx.com - Company Long-Term Debt|enGene - Company Long-Term Debts|Long-Term Debt rapt.com|JBIO (aerovatetx.com) - Company Long-Term Liabilities|Company Long-Term Indebtedness ACRS|Company Long-Term Liabilities KYTX|TLSA: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities CABA (Cabaletta Bio)|Amount of Long-Term Liabilities VTYX|Company Long-Term Debts THTX (Theratechnologies Inc)|Company Long-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Long-Term Debts|Long-Term Debt agenusbio.com|Climb Bio (CLYM) - Company Long-Term Debt|zurabio.com - Company Long-Term Loans and Borrowings|ATYR (aTyr) - Company Long-Term Debts|Company Long-Term Debts Adagene Corp|Company Long-Term Debt ImageneBio Inc (IMA)|STTK: Long-Term Liabilities|Company Long-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Long-Term Debt|IMUX: Company Long-Term Liabilities|ATRA - Company Long-Term Debts|IFRX (inflarx.de) - Company Long-Term Liabilities|XFOR: Amount of Long-Term Liabilities|ACET (Adicet Bio Inc.) - Company Long-Term Debts|Celularity Corp (CELU) - Long-Term Debt Volume|Company Long-Term Debts INMB|Company Long-Term Liabilities Barinthus Biotherapeutics Corp BRNS|Company Long-Term Debt Kezar Life Sciences KZR|Long-Term Debt Volume sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Company Long-Term Debts|Long-Term Debt Q32 Bio Inc.|GeoVax Labs Inc (GOVX) - Company Long-Term Debt|Company Long-Term Indebtedness EDSA|Company Long-Term Debt iBio, Inc.|Company Long-Term Debt CARM|Company Long-Term Liabilities XTLB (XTL Biopharmaceuticals Ltd.)|Company Long-Term Debt BOLT (boltbio.com)|Company Long-Term Debt HCW Biologics HCWB|APVO (Aptevo Therapeutics, Inc.) - Long-Term Liabilities|AIM ImmunoTech - Company Long-Term Debts|Company Long-Term Loans and Borrowings ADTX (Aditxt)|GRI: Company Long-Term Debts|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Debt ReShape Lifesciences|REVB: Company Long-Term Loans and Borrowings|Company Long-Term Debt Indaptus Therapeutics (INDP)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Debts Affimed NV AFMD|ALLK: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings HOOK (HOOKIPA Pharma Inc.)|IGMS: Company Long-Term Debts|ITOS - Long-Term Debt Volume|Company Long-Term Debt Ocean Biomedical|Company Long-Term Liabilities TC BioPharm (Holdings) Plc (TCBP)|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)